Helle Toldbod

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Francesco d’Amore, Thomas Relander, Grete F. Lauritzsen et al. · Journal of Clinical Oncology · 2012 · 584 citations

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

Anne Birgitte Als, Lars Dyrskjøt, Hans von der Maase et al. · Clinical Cancer Research · 2007 · 205 citations · Full text

Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial

Mats Jerkeman, Christian Winther Eskelund, Martin Hutchings et al. · The Lancet Haematology · 2018 · 145 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +7

Prediction and diagnosis of bladder cancer recurrence based on urinary content of hTERT, SENP1, PPP1CA, and MCM5 transcripts

Anne Sofie Brems-Eskildsen, Karsten Zieger, Helle Toldbod et al. · BMC Cancer · 2010 · 66 citations · Full text

Potent Influence of Bovine Serum Proteins in Experimental Dendritic Cell‐Based Vaccination Protocols

Helle Toldbod, Ralf Agger, Lars Bolund et al. · Scandinavian Journal of Immunology · 2003 · 36 citations · Full text